Editor-in-chief
Pr Ibrahim Yakoub-Agha, MD, PhD, Haematology, Head of the Immune Cellular Therapy Unit, Lille University Hospital, Lille, France

Associate Editors
Dr Tamim Alsuliman, MD, PhD, Dept.of Haematology and cellular therapy, Saint-Antoine hospital, APHP, Paris ; Sorbonne University, Paris, France: Hematology, oncology, hematopoietic cell transplantation and infectious diseases
Pr Halvard Bönig, MD, PhD, Dept. of Translational Development of Cellular Therapeutics, Institute for Transfusion Medicine and Immune Hematology, Johann-Wolfgang-Goethe Medical University, Frankfurt, Germany: Traansfusion Medicine, immunohematology, hematopoietic stem cells, hematopoietic stem cell transplantation, cell and gene therapy manufacturing, ATMP regulation, ATMP manufacturing
Dr Eolia Brissot, MD, PhD, Dept of Haematology and cellular therapy, Saint-Antoine hospital, APHP, Paris ; Sorbonne University, Paris, France: Hematology, acute leukemia, allogeneic and autologous stem cell transplantation, infections in immunocompromised patients
Pr Gandhi Damaj, MD, PhD, Dept. of Haematology, Caen University Hospital, Caen, France: Hematology, specifically lymphoma and mastocytosis, and other myeloproliferative neoplasms
Pr Monica Guzman, MD, PhD, Weil Cornell Medicine, Division of Hematology - Medical Oncology, Department of Medicine, New York, USA: hematopoietic stem cells, leukemia stem cells, clonal hematopoiesis, acute myeloid leukemia, and cell therapy
Dr Patrick Hayden, MD, PhD, Dept. of Haematology, Saint James hospital, Dublin, Ireland: Haematology, myeloma, stem cell transplantation and acute leukaemia
Dr Dania Humaidan, MD, PhD, Dept of Cognitive Modeling, Eberhard Karls University of Tuebingen and Max Planck International Research School for Intelligent Systems (IMPRS-IS), Tuebingen, Germany: Cognitive Modeling, Machine Learning, Computational Biology and Bioinformatic
Dr Muzaffer Ahmad Kassad, MD, PhD, Dept of Cancer, University of Pennsylvanian, Philadelphia, Pennsylvania, USA
Pr Myriam Labalette, MD, PhD, Lab of Immunology and HLA, Lille University Hospital, Lille, France: Lymphoma, Mastocytosis, Autologous HSC transplantation
Pr Jérôme Larghero, MD, PhD, Dept of Biotherapies, Saint Louis Hospital, Paris, France: Cell therapy, tissue engineering
Pr John A Snowden, MD, PhD, Consultant Haematologist & Director of Blood and Marrow Transplantation, Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, UK: Haemato-oncology (clinical and diagnostics), haematopoietic cell transplantation/cellular therapy (for malignant and non-malignant diseases)